These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20966644)

  • 1. The use of immunohistochemistry in the diagnosis of metastatic clear cell renal cell carcinoma: a review of PAX-8, PAX-2, hKIM-1, RCCma, and CD10.
    Sangoi AR; Karamchandani J; Kim J; Pai RK; McKenney JK
    Adv Anat Pathol; 2010 Nov; 17(6):377-93. PubMed ID: 20966644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical distinction of renal cell carcinoma from other carcinomas with clear-cell histomorphology: utility of CD10 and CA-125 in addition to PAX-2, PAX-8, RCCma, and adipophilin.
    Mentrikoski MJ; Wendroth SM; Wick MR
    Appl Immunohistochem Mol Morphol; 2014 Oct; 22(9):635-41. PubMed ID: 25279712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of PAX-2 in distinguishing metastatic clear cell renal cell carcinoma from its morphologic mimics: an immunohistochemical study with comparison to renal cell carcinoma marker.
    Gokden N; Gokden M; Phan DC; McKenney JK
    Am J Surg Pathol; 2008 Oct; 32(10):1462-7. PubMed ID: 18685487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of putative renal cell carcinoma markers PAX-2, PAX-8, and hKIM-1 in germ cell tumors: a tissue microarray study of 100 cases.
    Sangoi AR; McKenney JK; Brooks JD; Bonventre JV; Higgins JP
    Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):451-3. PubMed ID: 22495365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of PAX-2 and renal cell carcinoma marker immunohistochemistry in distinguishing papillary renal cell carcinoma from nonrenal cell neoplasms with papillary features.
    Sharma SG; Gokden M; McKenney JK; Phan DC; Cox RM; Kelly T; Gokden N
    Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):494-8. PubMed ID: 21102195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison.
    Ozcan A; de la Roza G; Ro JY; Shen SS; Truong LD
    Arch Pathol Lab Med; 2012 Dec; 136(12):1541-51. PubMed ID: 23194047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of carbonic anhydrase IX, PAX2 and PAX8 and their association with clinicopathologic characteristics in renal epithelial tumors].
    Zhang W; Yu WJ; Xia Y; Liu Y; Liu XL; Zhuang J; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):442-5. PubMed ID: 24246861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAX2 and PAX8: useful markers for metastatic effusions.
    Waters L; Crumley S; Truong L; Mody D; Coffey D
    Acta Cytol; 2014; 58(1):60-6. PubMed ID: 24334997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of PAX8, PAX2, napsin A, carbonic anhydrase IX, and claudin-4 immunostaining in distinguishing pleural epithelioid mesothelioma from metastatic renal cell carcinoma.
    Ordóñez NG
    Mod Pathol; 2013 Aug; 26(8):1132-43. PubMed ID: 23503645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAX2(-)/PAX8(-)/inhibin A(+) immunoprofile in hemangioblastoma: A helpful combination in the differential diagnosis with metastatic clear cell renal cell carcinoma to the central nervous system.
    Carney EM; Banerjee P; Ellis CL; Albadine R; Sharma R; Chaux AM; Burger PC; Netto GJ
    Am J Surg Pathol; 2011 Feb; 35(2):262-7. PubMed ID: 21263247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical distinction of primary adrenal cortical lesions from metastatic clear cell renal cell carcinoma: a study of 248 cases.
    Sangoi AR; Fujiwara M; West RB; Montgomery KD; Bonventre JV; Higgins JP; Rouse RV; Gokden N; McKenney JK
    Am J Surg Pathol; 2011 May; 35(5):678-86. PubMed ID: 21490444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of CD10 and RCCma in the diagnosis of metastatic conventional renal-cell adenocarcinoma by fine-needle aspiration biopsy.
    Simsir A; Chhieng D; Wei XJ; Yee H; Waisman J; Cangiarella J
    Diagn Cytopathol; 2005 Jul; 33(1):3-7. PubMed ID: 15945081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAX-2 in the diagnosis of primary renal tumors: immunohistochemical comparison with renal cell carcinoma marker antigen and kidney-specific cadherin.
    Ozcan A; Zhai J; Hamilton C; Shen SS; Ro JY; Krishnan B; Truong LD
    Am J Clin Pathol; 2009 Mar; 131(3):393-404. PubMed ID: 19228645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant variation of immunohistochemical marker expression in paired primary and metastatic clear cell renal cell carcinomas.
    Pan Z; Grizzle W; Hameed O
    Am J Clin Pathol; 2013 Sep; 140(3):410-8. PubMed ID: 23955461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic implications of transcription factor Pax 2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms.
    Gupta R; Balzer B; Picken M; Osunkoya AO; Shet T; Alsabeh R; Luthringer D; Paner GP; Amin MB
    Am J Surg Pathol; 2009 Feb; 33(2):241-7. PubMed ID: 18941400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human kidney injury molecule-1 (hKIM-1): a useful immunohistochemical marker for diagnosing renal cell carcinoma and ovarian clear cell carcinoma.
    Lin F; Zhang PL; Yang XJ; Shi J; Blasick T; Han WK; Wang HL; Shen SS; Teh BT; Bonventre JV
    Am J Surg Pathol; 2007 Mar; 31(3):371-81. PubMed ID: 17325478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sporadic renal hemangioblastoma with CA9, PAX2 and PAX8 expression: diagnostic pitfall in the differential diagnosis from clear cell renal cell carcinoma.
    Kuroda N; Agatsuma Y; Tamura M; Martinek P; Hes O; Michal M
    Int J Clin Exp Pathol; 2015; 8(2):2131-8. PubMed ID: 25973115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Useful immunohistochemical panel for differentiating clear cell papillary renal cell carcinoma from its mimics.
    Pramick M; Ziober A; Bing Z
    Ann Diagn Pathol; 2013 Oct; 17(5):437-40. PubMed ID: 23791764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system.
    Carvalho JC; Thomas DG; McHugh JB; Shah RB; Kunju LP
    Histopathology; 2012 Mar; 60(4):597-608. PubMed ID: 22260386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of PAX8 and PAX2 immunohistochemistry in the identification of renal cell carcinoma in diagnostic cytology.
    Knoepp SM; Kunju LP; Roh MH
    Diagn Cytopathol; 2012 Aug; 40(8):667-72. PubMed ID: 22807381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.